ARIAD Pharma (ARIA) Tops Q3 EPS by 3c

ARIAD Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $16.5 million.

For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings